Inhibikase Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 7K | 7K | 7K |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | -7K | -7K | -7K |
| R&D Expenses | 10.8M | 6.4M | 7.6M | 5.3M | 10.5M | 7.2M | 4.2M | 3.1M |
| Operating Expenses | 18.2M | 13.8M | 12.8M | 10.8M | 14.6M | 12.9M | 5.8M | 5.1M |
| Operating Income | -18.2M | -13.8M | -12.8M | -10.8M | -14.6M | -12.9M | -5.8M | -5.1M |
| Other Income / Gains | 1.8M | 1.0M | 838K | 917K | 919K | 796K | 49K | 91K |
| Net Income | -16.4M | -12.7M | -11.9M | -9.9M | -13.7M | -12.1M | -5.8M | -5.0M |
| EPS (Diluted) | -0.17 | -0.13 | -0.13 | -0.11 | -0.15 | -0.17 | -0.65 | -0.66 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 7.4M | 6.8M | 5.6M | 5.9M | 5.2M | 5.7M | 1.6M | 2.0M |
| Other Expenses | 0 | 642K | -493K | -358K | -1.2M | 0 | 0 | 0 |
| Cost And Expenses | 18.2M | 13.8M | 12.8M | 10.8M | 14.6M | 12.9M | 5.8M | 5.1M |
| Interest Income | 1.5M | 1.0M | 838K | 917K | 919K | 796K | 49K | 91K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 0 | 0 | 24K | 24K | 13K | 7K | 7K | 7K |
| Ebitda | -16.4M | -13.1M | -13.2M | -11.2M | -15.8M | -12.1M | -5.8M | -5.0M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -16.4M | -12.7M | -11.9M | -9.9M | -13.7M | -12.1M | -5.8M | -5.0M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.17 | -0.13 | -0.13 | -0.11 | -0.15 | -0.17 | -0.65 | -0.66 |
| Weighted Average Shs Out | 98.3M | 98.3M | 90.1M | 90.0M | 89.5M | 69.4M | 8.9M | 7.5M |
| Weighted Average Shs Out Dil | 98.3M | 98.3M | 90.1M | 90.0M | 89.5M | 69.4M | 8.9M | 7.5M |